Kromek’s final results for the year-ended 30 April 2025 reflect substantial growth as a result of landmark agreements signed with Siemens Healthineers, while demand in CBRN detection saw a strong recovery in 2H25. As a result, Kromek has announced revenue growth of 37% to £26.5m (our estimate £26.0m, FY24: £19.4m) with reported PBT of £3.1m (our estimate £1.9m, FY24: £3.5m loss) ahead of expectations. Year-end cash of £1.7m (30 April 2024: £0.5m) is supported by the $5m Siemens Healthineers mile ....
